Please assess the completion status of the following clinical trial:

Trial Title: Non-interventional Study With Ectoin Containing and/or Decongesting Nasal Spray in Patients With Rhinosinusitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients with acute viral rhinosinusitis~* presence of common cold symptoms~Exclusion Criteria:~* contraindications in accordance with instructions for use~* acute bacterial rhinosinusitis~* chronic rhinosinusitis

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ectoin Rhinosinusitis Nasal Spray (Type: None): application of 1-2 sprays of SNS01 into each nostril several times a day
- Xylometazoline nasal spray (Type: None): 1 spray per nostril as often as required but not exceeding 3 sprays per nostril per day
- Xylometazoline + Ectoin Nasal Spray (Type: None): Xylometazoline: 1 spray per nostril as often as required but not exceeding 3 sprays per nostril per day, Ectoin Nasal Spray (SNS01): 1-2 sprays per nostril several times a day

Based on this trial design, predict the completion outcome and termination type (if applicable).